哮喘急性发作的救治分析  

Treatment Analysis of Acute Asthma Attack

作　　者：张作鹏[1] 

机构地区：[1]广东省广州医学院第一附属医院,510120

出　　处：《中国医药指南》2010年第19期209-210,共2页Guide of China Medicine

摘　　要：目的观察舒利迭对支气管哮喘急性发作的临床疗效。方法将广州医学院第一附属医院2008年1月至2010年6月收治的急性发作期哮喘患者126例,随机分为两组,治疗组63例,对照组63例,两组均常规吸氧、祛痰、茶碱类药物、糖皮质激素应用、防止感染等常规治疗;治疗组在常规治疗基础上加用舒利迭(50/100μg),2次/d,连用10d。对照组在常规治疗基础上加用普米克令舒(吸入用布地奈德混悬液,规格1mg/支),2次/d,连用10d。观察两组症状、体征消失时间、临床疗效、肺功能改善及不良反应。结果治疗组总有效率94.0%,高于对照组84.1%,差异有统计学意义(P<0.05)。且治疗组症状、体征消失平均天数少于对照组,治疗组肺功能改善优于对照组,差异有统计学意义(P<0.05)。治疗组不良反应少于对照组。结论哮喘急性发作期雾化吸入舒利迭临床疗效好,不良反应少。Objective To observe the clinical effects of seretide treatment of acute asthma attack.Methods First affiliated hospital of Guangzhou medical college from January 2008 to June 2010 of acute exacerbation of asthma treated 126 patients were randomly divided into two groups,Both group was 63 patients,two groups of conventional oxygen,expectorants,theophylline drugs,glucocorticoidhormone application,to prevent infection and other conventional treatment;treatment group was treated based on the conventional treatment,added to use Seretide（50/100μg）,2 times/d,use 10 days.The control group was treated based on the conventional treatment,added to use Pulmicort Respules（budesonide inhalation suspension with specifications 1mg/support）,2 times/d,use 10 days.The symptoms and signs disappeared,clinical efficacy,pulmonary function improvement and side effects.Resultes Efficiency of the treatment group was 94.0%,higher than 84.1%,the difference was statistically significant（P〈0.05）.Treatment group symptoms and signs disappear average number of days than the control group,treatment group improved lung function than the control group,the difference was statistically significant（P〈0.05）.The adverse reactions than the control group.Conclusion Acute attack of asthma inhalation seretide clinical efficacy,adverse reactions.

关 键 词：哮喘 舒利迭 普米克令舒 

分 类 号：R562.25[医药卫生—呼吸系统]